FindTrial
Sign In

Study of hydromorphone or compound betamethasone as a local anesthetic adjuvant for TINB (thoracoscopic intercostal nerve block) during VATS (video-assisted thoracic surgery)

Study of hydromorphone or compound betamethasone as a local anesthetic adjuvant for TINB (thoracoscopic intercostal nerve block) during VATS (video-assisted thoracic surgery)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015517
Enrollment
Unknown
Registered
2018-04-04
Start date
2018-04-08
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Group A:intercostal nerve block of ropivacaine
Group B:intercostal nerve block of ropivacaine combine with hydromorphone
Group C:intercostal nerve block of ropivacaine combine with compound betamethasone

Sponsors

Huashan Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Aged from 18 to 60 years; 2) Scheduled for a VATS procedure by the same surgeon; 3) ASA I–II; 4) Good communication; 5) Eligible patients who agree to write informed consent.

Exclusion criteria

Exclusion criteria: 1) Allergy to ropivacaine, hydromorphone or compound betamethasone; 2) Communication difficulties; 3) A history of psychiatric illness; 4) Pregnancy; 5) Received other clinical trial in three months.

Design outcomes

Primary

MeasureTime frame
acute analgesic efficacy;—

Countries

China

Contacts

Public ContactHailian Wang

Huashan Hospital of Fudan University

wang-hai-lian@hotmail.com+86 13661672208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026